nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptive immune responses to SARS-CoV-2
|
Forthal, Donald |
|
|
172 |
C |
p. 1-8 |
artikel |
2 |
Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance
|
Bandari, Suresh |
|
|
172 |
C |
p. 52-63 |
artikel |
3 |
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
|
Hwang, Woochang |
|
|
172 |
C |
p. 249-274 |
artikel |
4 |
Dry powder pharmaceutical biologics for inhalation therapy
|
Chang, Rachel Yoon Kyung |
|
|
172 |
C |
p. 64-79 |
artikel |
5 |
Editorial board members
|
|
|
|
172 |
C |
p. ii |
artikel |
6 |
Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications
|
Mougin, Julie |
|
|
172 |
C |
p. 127-147 |
artikel |
7 |
(Macro)molecular self-assembly for hydrogel drug delivery
|
Webber, Matthew J. |
|
|
172 |
C |
p. 275-295 |
artikel |
8 |
Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics
|
Ropponen, Henni-Karoliina |
|
|
172 |
C |
p. 339-360 |
artikel |
9 |
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
|
Luo, Xiao-Min |
|
|
172 |
C |
p. 234-248 |
artikel |
10 |
Novel formulations and drug delivery systems to administer biological solids
|
Zhang, Yajie |
|
|
172 |
C |
p. 183-210 |
artikel |
11 |
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery
|
Deprez, J. |
|
|
172 |
C |
p. 9-36 |
artikel |
12 |
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
|
Liu, Huiqin |
|
|
172 |
C |
p. 37-51 |
artikel |
13 |
Pharmaceutical protein solids: Drying technology, solid-state characterization and stability
|
Chen, Yuan |
|
|
172 |
C |
p. 211-233 |
artikel |
14 |
Preclinical models and technologies to advance nanovaccine development
|
Peres, Carina |
|
|
172 |
C |
p. 148-182 |
artikel |
15 |
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
|
Chakraborty, Saborni |
|
|
172 |
C |
p. 314-338 |
artikel |
16 |
Translational oncotargets for immunotherapy: From pet dogs to humans
|
Mestrinho, Lisa A. |
|
|
172 |
C |
p. 296-313 |
artikel |
17 |
Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma
|
Liu, Yanhong |
|
|
172 |
C |
p. 80-103 |
artikel |
18 |
Versatility on demand – The case for semi-solid micro-extrusion in pharmaceutics
|
Rahman, Jhinuk |
|
|
172 |
C |
p. 104-126 |
artikel |